Eriko Nakata

464 total citations
17 papers, 387 citations indexed

About

Eriko Nakata is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Eriko Nakata has authored 17 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Eriko Nakata's work include Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (8 papers) and Pain Mechanisms and Treatments (5 papers). Eriko Nakata is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (8 papers) and Pain Mechanisms and Treatments (5 papers). Eriko Nakata collaborates with scholars based in Japan and United States. Eriko Nakata's co-authors include Yoshinori Katakura, Sanetaka Shirahata, Takumi Miura, Kazuhide Inoue, Yasushi Kuraishi, Yuta Matsumura, Atsushi Sasaki, Tomohiro Yamashita, Makoto Tsuda and Keita Kohno and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Eriko Nakata

16 papers receiving 378 citations

Peers

Countries citing papers authored by Eriko Nakata

Since Specialization

Citations

This map shows the geographic impact of Eriko Nakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Nakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Nakata more than expected).

Fields of papers citing papers by Eriko Nakata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Nakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Nakata. The network helps show where Eriko Nakata may publish in the future.

Co-authorship network of co-authors of Eriko Nakata

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Nakata. A scholar is included among the top collaborators of Eriko Nakata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Nakata. Eriko Nakata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Design and synthesis of novel δ opioid receptor agonists with an azatricyclodecane skeleton for improving blood-brain barrier penetration 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Daisuke Saito, Toshihiro Takahashi, Junichi Sakai, Eriko Nakata, Takashi Kanda, Takashi Iwai, Shigeto Hirayama, H. Fujii, Tomio Yamakawa, Hiroshi Nagase	6
2	Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Shigeto Hirayama, Takashi Iwai, (unknown), Toshihiro Takahashi, Junichi Sakai, Eriko Nakata, Tomio Yamakawa, H. Fujii, Hiroshi Nagase	5
3	Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure–activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivatives 2016 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Sachiko Mihara, Eriko Nakata, Chie Emoto, (unknown)	3
4	A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain 2016 ·Scientific Reports ·Yuta Matsumura, Tomohiro Yamashita, Atsushi Sasaki, Eriko Nakata, Keita Kohno, Takahiro Masuda, Hidetoshi Tozaki‐Saitoh, (unknown), Yasushi Kuraishi, Makoto Tsuda, Kazuhide Inoue	108
5	Development and validation of the Reality-Monitoring Error Experience Questionnaire 2014 ·The Japanese journal of psychology ·Eriko Nakata, (unknown)	0
6	Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure 2014 ·ACS Medicinal Chemistry Letters ·H. Fujii, (unknown), Akiyoshi Saitoh, (unknown), Shigeto Hirayama, Takashi Iwai, Eriko Nakata, Toru Nemoto, Yuka Sudo, Yasuhito Uezono, Mitsuhiko Yamada, Hiroshi Nagase	9
7	Efficient design, synthesis and structure–activity relationship studies of 1-(3′-substituted propyl)-4-arylpiperidines as non-peptide antagonists of nociceptin/orphanin FQ receptor: biological activities, metabolic stabilities and hERG channel bindings 2013 ·Medicinal Chemistry Research ·(unknown), (unknown), Eriko Nakata, Chie Emoto	1
8	Discovery of 1-(β-amino substituted-β-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: Efficient design, synthesis, and structure–activity relationship studies 2012 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Eriko Nakata, Chie Emoto	5
9	<b>Inhibition of P2X<sub>4</sub> receptor on spinal microglia </b><b>attenuates mechanical allodynia in experimental autoimmune neuritis rats </b> 2012 ·PAIN RESEARCH ·(unknown), Eriko Nakata, Kazuhide Inoue	7
10	Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: Design, synthesis, and structure–activity relationships 2010 ·Bioorganic & Medicinal Chemistry ·(unknown), Eriko Nakata, (unknown), (unknown), Kenzo Yamamura, (unknown), (unknown)	21
11	In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT4 receptor 2009 ·European Journal of Pharmacology ·(unknown), (unknown), Hiromi Sugimoto, Keiko Suzuki, (unknown), (unknown), (unknown), Eriko Nakata, Keigo Nakatani, (unknown), Hiroyuki Eda, (unknown)	4
12	Combined Memory and Executive Function Tests Can Screen Mild Cognitive Impairment and Converters to Dementia in a Community: The Osaki-Tajiri Project 2009 ·Neuroepidemiology ·Eriko Nakata, Mari Kasai, (unknown), Kyoko Akanuma, Mitsue Meguro, Hiroshi Ishii, Satoshi Yamaguchi, Kenichi Meguro	39
13	Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Design, Synthesis, and Structure−Activity Relationship of Oral Receptor Occupancy in the Brain for Orally Potent Antianxiety Drug 2009 ·Journal of Medicinal Chemistry ·(unknown), Akiko Hirao, Aki Imai, Hiroshi Nakamura, Yoshinori Murata, (unknown), Eriko Nakata	41
14	Decreased TumorigenicityIn VivoWhen Transforming Growth Factor β Treatment Causes Cancer Cell Senescence 2003 ·Bioscience Biotechnology and Biochemistry ·Yoshinori Katakura, Eriko Nakata, (unknown), Takumi Miura, Kiichiro Teruya, Toshie Tsuchiya, Sanetaka Shirahata	14
15	Structure−Activity Studies on Nociceptin Analogues: ORL1 Receptor Binding and Biological Activity of Cyclic Disulfide-Containing Analogues of Nociceptin Peptides 2001 ·Journal of Medicinal Chemistry ·Akihiro Ambo, (unknown), Yoshinari Yamada, Eriko Nakata, Yusuke Sasaki	16
16	Transforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer Cells 1999 ·Biochemical and Biophysical Research Communications ·Yoshinori Katakura, Eriko Nakata, Takumi Miura, Sanetaka Shirahata	96
17	Bidirectional Regulation of Telomerase Activity in a Subline Derived from Human Lung Adenocarcinoma 1997 ·Biochemical and Biophysical Research Communications ·Yoshinori Katakura, Katsuhiko Yamamoto, Osamu Miyake, Tomoharu Yasuda, Norihisa Uehara, Eriko Nakata, Seiji Kawamoto, Sanetaka Shirahata	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact